The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Biomarkers Across Neurodegenerative Diseases, 2014Interpreting Disease Heterogeneity in Alzheimer’s and Parkinson’s Disease
Study Rationale:
The memory loss that is commonly associated with Alzheimer’s disease is thought to be caused by the accumulation of a protein called amyloid that disrupts the structure and function of... -
Biomarkers Across Neurodegenerative Diseases, 2014Brain Networks as Targets of Neurodegeneration in Parkinson’s and Alzheimer’s Diseases
Study Rationale:
The study is based on two recent discoveries in neuroscience: (1) the brain is organized in large scale neuronal networks; (2) the misfolded proteins implicated in... -
Biomarkers Across Neurodegenerative Diseases, 2014Cortical and Functional Distinctions in Alzheimer’s and Parkinson’s Diseases
Study Rationale:
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are clinically distinct disorders, but their pathologies overlap considerably. Understanding how these overlaps relate to the two... -
Research Grant, 2014Detection of Alpha-Synuclein Oligomers for the Diagnosis of Parkinson's Disease
Study Rationale:
Parkinson's disease (PD) is associated with the presence of protein aggregates in the form of Lewy bodies composed of the protein alpha-synuclein. One of the... -
Rapid Response Innovation Awards, 2014Microvesicles: Biomarker and Vehicle for the Propagation of Pathological Forms of Alpha-synuclein
Study Rationale:
All living cells release extracellular vesicles composed of membrane proteins and lipids as well as components of the cell. These vesicles are important in cell-to-cell communication... -
Rapid Response Innovation Awards, 2014Role of Nicotinamide N-methyltransferase in Genetic Models of Parkinson’s Disease
Study Rationale:
There is mounting evidence linking the metabolism of the vitamin niacin to Parkinson’s disease (PD). The enzyme nicotinamide N-methyltransferase (NNMT), a key enzyme of the niacin...
![Two female doctors talking in the lab.](/sites/default/files/styles/ad_callout_single/public/images/ad/apply-for-grant-404-Large-Image-Callout-A-1.jpg?h=2a1ad497&itok=-_5jZ5iX)
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.